Efficacy of novel SPAK inhibitor ZT-1a derivatives (1c, 1d, 1g & 1h) on improving post-stroke neurological outcome and brain lesion in mice is a research paper published in Neurochemistry International (2022). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Veterans Affairs
Grant: IK6 BX005647
U.S. Department of Veterans Affairs
Grant: VA I01BX002891-01A1
National Institutes of Health
Grant: R01 NS166199-01A1
Royal Society
Grant: UK IEC\\NSFC\\201094
BLRD VA
Grant: I01 BX002891
BLRD VA
Grant: I01 BX006372
NINDS NIH HHS
Grant: R01 NS119166
Royal Society
U.S. Department of Veterans Affairs
National Institute of Neurological Disorders and Stroke
MeSH Terms
Keywords